Elucidation of the Mechanisms and Molecular Targets of Shuanglian Decoction for the Treatment of Hepatocellular Carcinoma Based on Network Pharmacology

[Image: see text] Shuanglian decoction (SLD) is traditionally used to treat hepatocellular carcinoma (HCC) in the clinical practice of traditional Chinese medicine. However, its mechanisms of action and molecular targets for the treatment of HCC are not clear. The active compounds of SLD were collec...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Kun, Chen, Hua, Cao, Tianshou, Lin, Jiantao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2020
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7808160/
https://www.ncbi.nlm.nih.gov/pubmed/33458543
http://dx.doi.org/10.1021/acsomega.0c05550

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7808160/
https://www.ncbi.nlm.nih.gov/pubmed/33458543
http://dx.doi.org/10.1021/acsomega.0c05550

Ejemplares similares